Wasting too much time searching for scientific articles and not enough time reading them?

Posted by Giovanni Ciavarra on Posted on

The volume of newly published scientific literature continues to grow at a staggering pace. A recent PubMed statistic indicates that the database hosts almost 29 million citations, with more than 1.3 million added in 2018 alone; a number that increased by 35% since 2013! And this accounts only for journals that are indexed by PubMed,
Read More

Malic Acid Under Fire in a Growing Number of Lawsuits and the Right Experts will be Key to Defending These Cases

Posted by Giovanni Ciavarra on Posted on

Malic acid is a versatile ingredient that is commonly found in food and dietary supplement products. Lately, malic acid has become the target of a growing number of lawsuits. Briefly, the suits allege that certain products are labeled as containing “no artificial flavors” but list malic acid as an ingredient. The suits continue by saying
Read More

Massive Talc Verdicts Will Encourage More Investment in the Litigation Industry Related to Asbestos

Posted by Giovanni Ciavarra on Posted on

In September, 2016 the firms of LSP Group, Innovative Science Solutions, and Assured Research collaborated to produce our second, in-depth and multidisciplinary analysis of the changes to and new directions in asbestos litigation. Our work included detailed thoughts on the scientific and legal developments, such as risks of more claims involving asbestos and cancers other
Read More

Litigation in the Pipeline for Liquid Filled Intragastric Balloon Systems?

Posted by Giovanni Ciavarra on Posted on

This post was authored by Sai Gandhe and Giovanni Ciavarra, PhD. Sai is a summer intern at Innovative Science Solutions and a senior at Case Western Reserve University studying systems biology and business management. Obesity has been associated with numerous health problems such as increased risk for heart disease, stroke, diabetes, high blood pressure, sleep
Read More

Biosimilar Patent Litigators Can Benefit from the Right Consulting and Testifying Experts

Posted by Giovanni Ciavarra on Posted on

The commercialization of biosimilars was enabled by the Biologics Price Competition and Innovation Act (BPCIA) of 2009 which was signed into law on March 22, 2010 as part of the Patient Protection and Affordable Care Act. Biologics are produced using living organisms, and thus, are usually much more complex than most small molecule drugs. Biosimilars
Read More

Opioid Litigation – The Defense Perspective [Download Conference Presentation Slides]

Posted by Giovanni Ciavarra on Posted on

The opioid litigation landscape continues to evolve, with over 200 lawsuits currently consolidated in the multidistrict litigation (MDL), In re: National Prescription Opiate Litiga­tion, MDL No. 2804, in the Northern Dis­trict of Ohio and being overseen by U.S. District Court Judge Dan Polster. New opioid cases continue to be filed (inside and outside of the
Read More

How to Find the Right Regulatory Experts for Your Case or Controversy

Posted by Giovanni Ciavarra on Posted on

Whether you are outside counsel retained in a pharmaceutical product liability case or in-house counsel responsible for a chemical manufacturer in a high-profile government investigation, having the right regulatory expert can be the difference between remarkable success and high stakes failure. What should you look for in an expert? In selecting the best regulatory expert,
Read More

Mitigating the Risk of Adverse Drug Reactions in Pharmacogenomic-Inspired Litigation

Posted by Giovanni Ciavarra on Posted on

This post was drafted by Innovative Science Solutions and Wendell S. Fortson, founder of Fortson Strategies, LLC.  Fortson Strategies is a national cancer litigation strategy firm for corporations. The firm’s focus is oncology-related matters involving patent, toxic torts and products liability litigation. It is well-established that not every individual responds the same way to a
Read More

3 Steps to Recruiting the Ideal Expert Witness

Posted by Giovanni Ciavarra on Posted on

This article was authored by Ted Dunkelberger, who provides expertise in litigation strategy and expert recruitment at ISS. Ted has consulted with corporations and defense counsel on mass tort and complex litigation for over 26 years. Mr. Dunkelberger has worked with individual clients and industry groups on some of the country’s largest and most prominent
Read More

Opiate Litigation: What’s on the Horizon?

Posted by Giovanni Ciavarra on Posted on

In 1996, James Campbell, a neurosurgeon at Johns Hopkins Medical School, gave a keynote speech at the American Pain Society’s annual conference. Campbell argued that hospitals must change their views on pain management by treating it as “The Fifth Vital Sign,” elevating it to the importance of collecting standard signs and symptoms (e.g., blood pressure, temperature, heart rate, and respiratory rate) as part of a standard medical exam.
Read More